Naba Al Saha Medical Services Company (TADAWUL: 9546)

Naba Al Saha Medical Services Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	196.78	182.35	129.68	117.68	115.68
Revenue Growth (YoY)	32.40%	40.61%	10.20%	1.73%	-
Cost of Revenue	127.11	110.57	79.8	72.32	70.77
Gross Profit	69.67	71.78	49.88	45.36	44.92
Selling, General & Admin	29.8	27.94	19.32	17.54	17.35
Operating Expenses	29.8	27.94	20.07	17.54	17.35
Operating Income	39.87	43.84	29.81	27.82	27.57
Interest Expense	-0.22	-0.21	-0.21	-0.25	-0.3
Earnings From Equity Investments	-1.02	-0.72	-0.13	-	-
Other Non Operating Income (Expenses)	1.81	2.28	-0.53	-0.04	1.07
EBT Excluding Unusual Items	40.45	45.21	28.93	27.53	28.34
Asset Writedown	2.33	2.33	-	-	-
Other Unusual Items	-2.33	7.33	-	-	-
Pretax Income	40.45	54.86	28.93	27.53	28.34
Income Tax Expense	2.79	2.48	2.01	1.7	1.68
Net Income	37.66	52.38	26.92	25.83	26.65
Net Income to Common	37.66	52.38	26.92	25.83	26.65
Net Income Growth	-4.18%	94.57%	4.24%	-3.10%	-
Shares Outstanding (Basic)	11	11	11	11	-
Shares Outstanding (Diluted)	11	11	11	11	-
EPS (Basic)	3.59	4.99	2.56	2.46	-
EPS (Diluted)	3.59	4.99	2.56	2.46	-
EPS Growth	-4.18%	94.57%	4.24%	-	-
Free Cash Flow	-18.5	-9.51	27.95	20.37	-33.6
Free Cash Flow Per Share	-1.76	-0.91	2.66	1.94	-
Dividend Per Share	-	-	0.200	0.200	-
Gross Margin	35.41%	39.36%	38.46%	38.55%	38.83%
Operating Margin	20.26%	24.04%	22.98%	23.64%	23.83%
Profit Margin	19.14%	28.73%	20.76%	21.95%	23.04%
Free Cash Flow Margin	-9.40%	-5.21%	21.55%	17.31%	-29.05%
EBITDA	48.39	51.53	35	32.47	32.18
EBITDA Margin	24.59%	28.26%	26.99%	27.59%	27.82%
D&A For EBITDA	8.51	7.68	5.2	4.65	4.61
EBIT	39.87	43.84	29.81	27.82	27.57
EBIT Margin	20.26%	24.04%	22.98%	23.64%	23.83%
Effective Tax Rate	6.91%	4.52%	6.95%	6.18%	5.94%

Source: S&P Capital IQ. Standard template. Financial Sources.